Skip to content
Clinical Trials – home

HNO Praxis Dr. Sonja Runge

Research site

Germany Rosa-Luxemburg-Damm 1, 15366 Neuenhagen, Germany

  • 2 trials recruiting
  • Conjunctivitis allergic · Pharyngitis · Rhinitis allergic
  • Adults and children

About Specializations

HNO Praxis Dr. Sonja Runge in Neuenhagen, Germany specialises in clinical trials of conditions such as Conjunctivitis allergic, Pharyngitis, Rhinitis allergic, Seasonal allergy, and other specialisations. This site conducts important research.

Main research areas of the site

Allergy and Immunotherapy

The medical center is at the forefront of research in allergy and immunotherapy, focusing on innovative treatments for allergic conditions. The center's work is particularly concentrated on allergic rhinitis and rhinoconjunctivitis induced by house dust mite (HDM) allergies, with or without associated asthma.

  • Subcutaneous Immunotherapy (SCIT)
  • Allergic Rhinitis and Rhinoconjunctivitis
  • House Dust Mite Allergy

Through rigorous clinical trials, the center evaluates the efficacy of advanced immunotherapy treatments, aiming to improve the quality of life for patients with moderate to severe allergic conditions. The research contributes significantly to the development of personalized therapeutic strategies, enhancing patient outcomes in allergy management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Rosa-Luxemburg-Damm 115366 NeuenhagenGermany
Recruiting now
2 trials
Conditions studied
4

More sites in NeuenhagenGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited

Pharyngitis

Recruiting

Testing benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 dichlorobenzyl alcohol
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Conjunctivitis allergic

Not yet recruiting

Study on the Effectiveness and Safety of PQ Birch for Patients with Seasonal Allergic Rhinitis or Rhinoconjunctivitis from Birch Pollen

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Allergy Therapeutics (UK) Limited

Pharyngitis

Not yet recruiting

Study of benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for treating acute pharyngitis symptoms

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 dichlorobenzyl alcohol
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG

Conjunctivitis allergic+1

Not recruiting

Study on Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Betula Pendula Pollen Allergoid, Mannan-Conjugated, Polymerised
  • Sponsor:CCDRD Cooperative Clinical Drug Research and Development AG

Conjunctivitis allergic+1

Not recruiting

Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Aluminium Hydroxide
  • Sponsor:HAL Allergy B.V.

Conjunctivitis allergic+1

Not recruiting

Dose‑finding trial of a mannan‑conjugated Phleum pratense/Dactylis glomerata allergoid vaccine in patients with grass‑pollen allergic rhinitis or rhinoconjunctivitis

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.

Study on the Safety and Effectiveness of Betula Pollen Extract for Children and Adolescents Aged 5-17 with Birch Pollen Allergies and Possible Asthma

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Betula Pollen Extract
  • Sponsor:Stallergenes

Conjunctivitis allergic+1

Not recruiting

Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Bilastine
  • Sponsor:Inmunotek S.L.
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.